Skip to main content

Pemoline Pregnancy and Breastfeeding Warnings

Brand names: Cylert

Pemoline Pregnancy Warnings

Pemoline has been assigned to pregnancy category B by the FDA. Animal studies have revealed evidence of increased incidence of stillbirths, and a decreased rate of postnatal survival of offspring. There are no controlled data in human pregnancy. Pemoline should be given during pregnancy when need has been clearly established.

See references

Pemoline Breastfeeding Warnings

There are no data on the excretion of pemoline into human milk. Because many drugs are excreted into human milk, caution is recommended if the drug is to be used in a nursing woman.

See references

See also

References for pregnancy information

  1. (2001) "Product Information. Cylert (pemoline)." Abbott Pharmaceutical

References for breastfeeding information

  1. (2001) "Product Information. Cylert (pemoline)." Abbott Pharmaceutical

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer